MYOS RENS is evaluating the genotypic characteristics and molecular pathways that contribute to the changes seen in muscle and inflammatory disease states associated with sarcopenia and related disorders.
MYOS RENS takes its responsibility to the environment and the community very seriously. MYOS RENS is committed to being a good corporate citizen and welcomes suggestions on enhancing our contributions in this regard.
Mannello Foregoes Salary for Options Exerciseable at $4.00 per Share
CEDAR KNOLLS, N.J., Sept. 20, 2017 /PRNewswire/ -- MYOS RENS Technology Inc. ("MYOS" or "the Company") (NASDAQ: MYOS), a biotherapeutics and bionutrition company, today announced that it has entered into an employment agreement with Joseph Mannello to serve as its permanent [...]
Over 10,000 Fitness, Wellness, Nutrition, Business and Mind-Body Professionals Will Be In Attendance As MYOS RENS Rolls Out Its 90-Day Qurr® Challenge
CEDAR KNOLLS, N.J., July 12, 2017 /PRNewswire/ -- MYOS RENS Technology Inc. ("MYOS" or "the Company") (NASDAQ: MYOS), announced today that it will be a sponsor at this year's IDEA World [...]